23rd August 2019
After the Hackathon, the teams will be progressing to the next stage in seeking support for their healthcare innovations
Six teams have emerged successful from the 31 March-5 April 2019 Wild Card Hackathon, which saw 35 hopeful entrepreneurs from across Europe convene in Amsterdam to work through a number of tasks designed to encourage teamwork and improve business skills.
A total of 19 participants belong to the EIT Health Wild Card teams that have been selected to continue to the next stage of the programme, which will be held in Paris starting in May.
This upcoming Business Model Validation stage will be a ten-week journey of intensive mentoring and customer discovery that participants go through before entering the final pitch contest in July.
The two teams winning that pitch contest will share in a total of €4 million in funding and receive further support in bringing their innovative products or solutions to market. The teams have each chosen to work on one of two challenges:
- Digital Biomarkers: Improving early diagnostics with the application of digital biomarkers.
- Brain and Mental Health: Improving prediction, diagnosis and treatment to fight mental disorders and strengthen brain health.
“During the Hackathon, the participants were tested on their team-building qualities as much as their business healthcare innovation proposals,” EIT Health Director of Innovation Jorge Fernandez Garcia said. “We have selected teams who have shown real potential to perform well together, in order to identify the specific unmet needs within the Wild Card challenge areas and find feasible, impactful solutions to address them.”
The winning teams
The six teams progressing to the next stage following the Hackathon are:
Digital Biomarker challenge:
- BioDTek: Enrique Hernandez, Eduard Guerrero, Erika Plata, Francisco Jesus Aloa and Edilberto Ojeda.
- Dinosis: Miguel Amador, Jane Bourgninaud and Andreu Oliver.
- Phi: Mahmoud Tavakoli and Pedro Lopes.
Brain and Mental Health challenge:
- iLoF: Luis Valente and Joana Paiva.
- Panthera: Alfonso Maria Ponsiglione, Clemens Lowik and Kranthi Panth.
- Pipra: John Klepper, Nick Gklezakos, Nayeli Schmutz and Benjamin Dodsworth.
Starting in early May, in Paris at the ICM (Brain and Spine Institute), the finalists will work more closely with their mentors to test their hypotheses, validate and develop value propositions, and identify appropriate business models for their proposed solutions to meet the Wild Card healthcare challenges. The mentors will be supporting the teams through a series of sessions looking at key issues in innovation and entrepreneurship, such as intellectual property, de-risking projects and business economics.
Wild Card finalist 2019 Miguel Amador said: “The week in Amsterdam was a great experience and allowed me to find other likeminded people who are passionate about making a change in healthcare. Our team is delighted to be one of the finalists moving on to the next stage of the Wild Card programme.”
Find out more about Wild Card here:
- EIT Health activity page
- Wild Card website
EIT Health rewards societal impact at Pitch Contest
Amparo takes 1st place at MedtecLIVE
EIT Health supported Optellum in AI world-first
Breakthrough in lung cancer detection technology
EIT Health-entrepreneur on Medicine’s Maker ‘Power List’
Evelina Vågesjö, CEO at Ilya Pharma